HIV/AIDS is a major public health problem. Despite the advances in HIV treatment, the cure for all HIV patients still possesses a major challenge, which needs to be surpassed in coming years. One attractive target is HIV-1 Protease. Herein we report a new series of HIV-1 Protease Inhibitors incorporating stereo chemically defined tetrahydrofuran-tertiary amine-acetamide P2 ligand. Structure activity relationship studies like 2D QSAR, ADME studies and Molecular Docking were performed to design a chemical entity. A total of 37 compounds were chosen for this study divided into Training and Test set. A total of 27 training set molecules were taken for the SAR analysis (2D QSAR). The model was seen to have an incredible Correlation coefficient (R = 0.942) and also exhibited good predictive power confirmed by the high value of cross validated correlation coefficient (Q2 = 0.701). The outcome of this study gives us an insight for designing novel and peculiar HIV-1 Protease Inhibitors and provides us a guideline for designing compounds with improved novel HIV virus inhibitory potential.
Seitz, R. (2016) Human Immunodeficiency Virus (HIV). TransfusionMedicineandHemotherapy, 43, 203-222. https://doi.org/10.1159/000445852
Van Heuverswyn, F., Li, Y., Neel, C., Bailes, E., Keele, B.F., Liu, W., et al. (2006) Human Immunodeficiency Viruses: SIV Infection in Wild Gorillas. Nature, 444, 164-164. https://doi.org/10.1038/444164a
Deeks, S.G., Overbaugh, J., Phillips, A. and Buchbinder, S. (2015) HIV Infection. NatureReviewsDiseasePrimers, 1, Article No. 15035. https://doi.org/10.1038/nrdp.2015.35
Campbell-Yesufu, O.T. and Gandhi, R.T. (2011) Update on Human Immunodeficiency Virus (HIV)-2 Infection. ClinicalInfectiousDiseases, 52, 780-787. https://doi.org/10.1093/cid/ciq248
Hernandez-Vargas, E.A. and Middleton, R.H. (2013) Modeling the Three Stages in HIV Infection. JournalofTheoreticalBiology, 320, 33-40. https://doi.org/10.1016/j.jtbi.2012.11.028
Mindel, A. (2001) ABC of AIDS: Natural History and Management of Early HIV Infection. BMJ, 322, 1290-1293. https://doi.org/10.1136/bmj.322.7297.1290
Fearon, M. (2005) The Laboratory Diagnosis of HIV Infections. CanadianJournalofInfectiousDiseasesandMedicalMicrobiology, 16, 26-30. https://doi.org/10.1155/2005/515063
Cihlar, T. and Fordyce, M. (2016) Current Status and Prospects of HIV Treatment. CurrentOpinioninVirology, 18, 50-56. https://doi.org/10.1016/j.coviro.2016.03.004
Fettig, J., Swaminathan, M., Murrill, C.S. and Kaplan, J.E. (2014) Global Epidemiology of HIV. InfectiousDiseaseClinicsofNorthAmerica, 28, 323-337. https://doi.org/10.1016/j.idc.2014.05.001
Yang, H., Nkeze, J. and Zhao, R.Y. (2012) Effects of HIV-1 Protease on Cellular Functions and Their Potential Applications in Antiretroviral Therapy. Cell&Bioscience, 2, Article No. 32. https://doi.org/10.1186/2045-3701-2-32
Gulnik, S., Erickson, J.W. and Xie, D. (2000) HIV Protease: Enzyme Function and Drug Resistance. Vitamins&Hormones, 58, 213-256. https://doi.org/10.1016/s0083-6729(00)58026-1
Surabhi, S. and Singh, B. (2018) Computer Aided Drug Design: An Overview. JournalofDrugDeliveryandTherapeutics, 8, 504-509. https://doi.org/10.22270/jddt.v8i5.1894
Jain, A. (2017) Computer Aided Drug Design. JournalofPhysics: ConferenceSeries, 884, Article ID: 012072. https://doi.org/10.1088/1742-6596/884/1/012072
Macalino, S.J.Y., Gosu, V., Hong, S. and Choi, S. (2015) Role of Computer-Aided Drug Design in Modern Drug Discovery. ArchivesofPharmacalResearch, 38, 1686-1701. https://doi.org/10.1007/s12272-015-0640-5
Sinha, S. and Vohora, D. (2018) Drug Discovery and Development. In: Vohora, D. and Singh, G., Eds., PharmaceuticalMedicineandTranslationalClinicalResearch, Elsevier, 19-32. https://doi.org/10.1016/b978-0-12-802103-3.00002-x
Khazir, J., Mir, B.A., Mir, S.A. and Cowan, D. (2013) Natural Products as Lead Compounds in Drug Discovery. JournalofAsianNaturalProductsResearch, 15, 764-788. https://doi.org/10.1080/10286020.2013.798314
de Souza Neto, L.R., Moreira-Filho, J.T., Neves, B.J., Maidana, R.L.B.R., Guimarães, A.C.R., Furnham, N., et al. (2020) In Silico Strategies to Support Fragment-To-Lead Optimization in Drug Discovery. FrontiersinChemistry, 8, Article 93. https://doi.org/10.3389/fchem.2020.00093
Merchant, H.A. (2021) Basic Pharmacokinetics. In: Batchelor, H., Ed., Biopharmaceutics: From Fundamentals to Industrial Practice, Wiley. https://doi.org/10.1002/9781119678366.ch2
van den Anker, J., Reed, M.D., Allegaert, K. and Kearns, G.L. (2018) Developmental Changes in Pharmacokinetics and Pharmacodynamics. TheJournalofClinicalPharmacology, 58, S10-S25. https://doi.org/10.1002/jcph.1284
Jones, L.H. and Bunnage, M.E. (2017) Applications of Chemogenomic Library Screening in Drug Discovery. NatureReviewsDrugDiscovery, 16, 285-296. https://doi.org/10.1038/nrd.2016.244
Abdel-Ilah, L., Veljović, E., Gurbeta, L. and Badnjević, A. (2017) Applications of QSAR Study in Drug Design. International Journal of Engineering Research & Technology, 6, 582-587.
Lewis, R.A. and Wood, D. (2014) Modern 2D QSAR for Drug Discovery. WIREs ComputationalMolecularScience, 4, 505-522. https://doi.org/10.1002/wcms.1187
Aparoy, P., Kumar Reddy, K. and Reddanna, P. (2012) Structure and Ligand Based Drug Design Strategies in the Development of Novel 5-LOX Inhibitors. CurrentMedicinalChemistry, 19, 3763-3778. https://doi.org/10.2174/092986712801661112
Fan, J., Fu, A. and Zhang, L. (2019) Progress in Molecular Docking. QuantitativeBiology, 7, 83-89. https://doi.org/10.1007/s40484-019-0172-y
Bai, X., Yang, Z., Zhu, M., Dong, B., Zhou, L., Zhang, G., et al. (2017) Design and Synthesis of Potent HIV-1 Protease Inhibitors with (S)-Tetrahydrofuran-Tertiary Amine-Acetamide as P2-ligand: Structure-Activity Studies and Biological Evaluation. EuropeanJournalofMedicinalChemistry, 137, 30-44. https://doi.org/10.1016/j.ejmech.2017.05.024
Anthony-Cahill, S. and Walsh, E.J. (1999) Book & Media Reviews. Journal of Chemical Education, 76, 905-906. https://doi.org/10.1021/ed076p905
Spessard, G.O. (1998) ACD Labs/LogP dB 3.5 and ChemSketch 3.5. JournalofChemicalInformationandComputerSciences, 38, 1250-1253. https://doi.org/10.1021/ci980264t
Chen, H., Kogej, T. and Engkvist, O. (2018) Cheminformatics in Drug Discovery, an Industrial Perspective. MolecularInformatics, 37, Article ID: 1800041. https://doi.org/10.1002/minf.201800041
Weininger, D. (1988) SMILES, a Chemical Language and Information System. 1. Introduction to Methodology and Encoding Rules. JournalofChemicalInformationandComputerSciences, 28, 31-36. https://doi.org/10.1021/ci00057a005
Pires, D.E.V., Blundell, T.L. and Ascher, D.B. (2015) PKCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. JournalofMedicinalChemistry, 58, 4066-4072. https://doi.org/10.1021/acs.jmedchem.5b00104
Lombardo, F., Shalaeva, M.Y., Tupper, K.A. and Gao, F. (2001) ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds. JournalofMedicinalChemistry, 44, 2490-2497. https://doi.org/10.1021/jm0100990
Pecoraro, B., Tutone, M., Hoffman, E., Hutter, V., Almerico, A.M. and Traynor, M. (2019) Predicting Skin Permeability by Means of Computational Approaches: Reliability and Caveats in Pharmaceutical Studies. JournalofChemicalInformationandModeling, 59, 1759-1771. https://doi.org/10.1021/acs.jcim.8b00934
Doniger, S., Hofmann, T. and Yeh, J. (2002) Predicting CNS Permeability of Drug Molecules: Comparison of Neural Network and Support Vector Machine Algorithms. JournalofComputationalBiology, 9, 849-864. https://doi.org/10.1089/10665270260518317
Lee, D.K., In, J. and Lee, S. (2015) Standard Deviation and Standard Error of the Mean. KoreanJournalofAnesthesiology, 68, 220-223. https://doi.org/10.4097/kjae.2015.68.3.220
Hughes, J., Rees, S., Kalindjian, S. and Philpott, K. (2011) Principles of Early Drug Discovery. BritishJournalofPharmacology, 162, 1239-1249. https://doi.org/10.1111/j.1476-5381.2010.01127.x
Pavlov, A., Takuchev, N. and Georgieva, N. (2012) Drug Design by Regression Analyses of Newly Synthesized Derivatives of 8-Quinolinol. Biotechnology&BiotechnologicalEquipment, 26, 164-169. https://doi.org/10.5504/50yrtimb.2011.0030